An unprecedented gene editing treatment that could lead to curing HIV.
The person who received the first single-dose intravenous infusion EBT-101 therapy is being observed and evaluated for rebound of the HIV virus. Since this treatment has never been done before, researchers want to make sure the treatment stops the virus from replicating itself in the body. The research team is hoping that the individual will no longer need to use the antiretroviral therapy, which is currently the standard in HIV treatment.The trial was launched by Kamel Khalili, PhD, Laura H.
Dr. Khalili mentioned that there are still no curative treatments for HIV after more than 40 years since the virus was discovered. Nearly 40 million people worldwide suffer from HIV. He said “EBT-101 can potentially address long-standing unmet needs of individuals living with HIV/AIDS by removing viral DNA from their cells, thereby eradicating infection.”The trial is a study meant to evaluate the safety and efficacy of EBT-101 in approximately nine participants living with HIV-1.
The inaugural assessment of Phase 1/2 clinical trials for EBT-101 serves as a hopeful indicator to the team who believe they are closer to creating this
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Health apps share your concerns with advertisers. HIPAA can’t stop it.From “depression” to “HIV,” we found popular health apps sharing potential health concerns and user identifiers with dozens of ad companies.
Lire la suite »
HIV crashed her life. She found her way back to joy — and spoke at the U.N. this weekDiagnosed with HIV before her wedding, Bupe Sinkala didn't tell her husband and saw her marriage — and life — crumble. Now she's a community health worker advocating for her unsung profession.
Lire la suite »
There’s New Proof Crispr Can Edit Genes Inside Human BodiesThe technique had largely been limited to editing patients’ cells in the lab. New research shows promise for treating diseases more directly.
Lire la suite »